GeoVax, PharmaJet partner to study needle-free delivery of Zika vaccine

GeoVax Labs Inc. (OTCQB:GOVX) partnered with PharmaJet Inc. (Golden, Colo.) to evaluate PharmaJet’s needle-free injection system to deliver GeoVax’s preclinical Zika vaccine GEO-ZM02.

The studies will be conducted at the Division of Vector-Borne Diseases, U.S. Centers for Disease Control and Prevention (CDC) in Fort Collins, Colo. with technical assistance from the CDC. Further analysis will be conducted in the laboratories at GeoVax...